Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Allarity Therapeutics, Inc. (ALLR) had Free Cash Flow per Share of $-10.98 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-25.15M |
|
-- |
|
-- |
|
$27.24M |
|
$-27.24M |
|
$2.35M |
|
$-24.90M |
|
$-24.90M |
|
$-24.52M |
|
$-24.52M |
|
$-24.52M |
|
$-24.52M |
|
$-27.24M |
|
$-17.53M |
|
1.61M |
|
1.61M |
|
$-15.65 |
|
$-15.65 |
|
| Balance Sheet Financials | |
$22.34M |
|
$0.31M |
|
$0.31M |
|
$22.65M |
|
$10.84M |
|
-- |
|
-- |
|
$10.84M |
|
$11.81M |
|
$11.81M |
|
$11.81M |
|
7.30M |
|
| Cash Flow Statement Financials | |
$-17.35M |
|
$-0.30M |
|
$36.79M |
|
$0.17M |
|
$19.53M |
|
$19.37M |
|
$0.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.06 |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.65M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-207.56% |
|
-207.56% |
|
-108.23% |
|
-207.56% |
|
$1.62 |
|
|
Free Cash Flow per Share |
$-10.98 |
$-10.80 |
|